Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Accenture
UBS
Federal Trade Commission
Harvard Business School
Daiichi Sankyo
Healthtrust
Baxter

Generated: July 17, 2018

DrugPatentWatch Database Preview

Triprolidine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for triprolidine hydrochloride and what is the scope of triprolidine hydrochloride patent protection?

Triprolidine hydrochloride
is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Usl Pharma, Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for triprolidine hydrochloride.
Summary for triprolidine hydrochloride
US Patents:0
Tradenames:3
Applicants:7
NDAs:8
Drug Master File Entries: 13
Bulk Api Vendors: 32
Patent Applications: 759
DailyMed Link:triprolidine hydrochloride at DailyMed
Medical Subject Heading (MeSH) Categories for triprolidine hydrochloride
Synonyms for triprolidine hydrochloride
(E)-2-(3-(Pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine hydrochloride
(E)-2-[1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]PYRIDINE HYDROCHLORIDE
(E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
1-[(2E)-3-(4-methylphenyl)-3-(pyridin-2-yl)prop-2-en-1-yl]pyrrolidinium chloride
138T790
2-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]pyridine Hydrochloride
2-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine hydrochloride
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
295 C 51
295C51
486-12-4 (Parent)
550-70-9
6138-79-0
AC-15905
AC1NWAR4
Actidilat
Actidilon
AK487173
AKOS015962154
AS-13971
C19H22N2.HCl
CCG-40331
CHEBI:84119
CHEMBL1200450
DTXSID10872513
EINECS 208-985-0
Entra
EU-0101130
FT-0082802
HE061157
HMS1568F06
HMS1921I07
LP01130
LS-131942
MFCD00039044
MLS000028751
MLS001148254
MLS002207213
MLS002222226
MolPort-003-666-303
NCGC00094397-01
NCGC00094397-02
NCGC00094397-03
NCGC00261815-01
NG7A104R3J
NSC-757361
NSC757361
Opera_ID_1214
Pharmakon1600-01500598
Prestwick_575
Pro-Actidil
Pro-Entra
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1)
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride
Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, (E)-
Pyridine, 2-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-, hydrochloride (1:1)
SCHEMBL42145
SMR000058521
SPECTRUM1500598
SR-01000075292
SR-01000075292-1
T 6764
Tox21_501130
trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene Hydrochloride
trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride
trans-2-[3-(1-Pyrrolidinyl)-1-(p-tolyl)propenyl]pyridine Hydrochloride
trans-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
trans-Triprolidine hydrochloride
triprolidine hydrochloride (anh.)
Triprolidine Hydrochloride (anhydrous)
Triprolidine hydrochloride anhydrous
Triprolidine hydrochloride, >=99%
Triprolidine hydrochloride, Sigma Reference Standard
Triprolidine Monohydrochloride
triprolidine monohydrochloride (anh.)
triprolidine monohydrochloride (anhydrous)
triprolidine monohydrochloride anhydrous
UNII-NG7A104R3J
V1639
Venen

US Patents and Regulatory Information for triprolidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma MYIDYL triprolidine hydrochloride SYRUP;ORAL 087963-001 Jan 18, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride TABLET;ORAL 085610-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 087514-001 Feb 10, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline ACTIDIL triprolidine hydrochloride TABLET;ORAL 011110-002 Jul 1, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Moodys
Accenture
Chinese Patent Office
Merck
Argus Health
Julphar
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.